The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997

The Hematology Journal : the Official Journal of the European Haematology Association
N L HarrisClara D Bloomfield

Abstract

Since 1995, the European Association of Pathologists and the Society for Hematopathology have been developing a new World Health Organization (WHO) classification of hematologic malignancies. The classification includes lymphoid, myeloid, histiocytic, and mast cell neoplasms. The WHO project involves ten committees of pathologists, who have developed lists and definitions of disease entities. A Clinical Advisory Committee (CAC) of international hematologists and oncologists was formed to ensure that the classification will be useful to clinicians. A meeting was held in November 1997 to discuss clinical issues related to the classification. WHO has adopted the 'Revised European-American Classification of Lymphoid Neoplasms' (REAL), published in 1994 by the International Lymphoma Study Group (ILSG), as the classification of lymphoid neoplasms. This approach to classification is based on the principle that a classification is a list of 'real' disease entities, which are defined by a combination of morphology, immunophenotype, genetic features, and clinical features. The relative importance of each of these features varies among diseases, and there is no one 'gold standard'. The WHO classification has applied the principles of the ...Continue Reading

Citations

Jun 3, 2004·The Journal of Clinical Investigation·Irma AiroldiVito Pistoia
May 27, 2005·Journal of Clinical Pathology·G Kocjan
Jul 4, 2007·Haematologica·Christine F SkibolaAlexandra Nieters
Jan 1, 2011·Revista brasileira de hematologia e hemoterapia·Bruno Kosa Lino DuarteCarmino Antonio de Souza
Mar 11, 2015·Cancer Immunology, Immunotherapy : CII·Takumi KumaiYasuaki Harabuchi
Sep 7, 2002·American Journal of Hematology·Birgitta SwolinGösta Roupe
Apr 8, 2004·World Journal of Gastroenterology : WJG·Seong-Ho KongKuk-Jin Choe
Feb 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Armando López-GuillermoEmili Montserrat
Mar 11, 2006·Pediatric Hematology and Oncology·Georg MannUNKNOWN Austrian Berlin-Frankfurt-Münster (BFM) Group
Sep 1, 2006·Current Treatment Options in Neurology·Hendrik Pels, Uwe Schlegel
Aug 23, 2006·Future Oncology·Victor YazbeckAnas Younes
Apr 10, 2007·Pediatric Blood & Cancer·Veronique DinandRamesh Dawar
Mar 21, 2007·British Journal of Haematology·Francine Garnache-OttouPhilippe Saas
Oct 6, 2006·European Radiology·Eric de KervilerJacques Frija
Mar 25, 2009·American Journal of Clinical Oncology·Chantal S LegerLinda M Vickars
Mar 2, 2010·Journal of Korean Medical Science·Jae Myung ChaGyo Young Kim
Dec 4, 2009·American Journal of Hematology·Kebede HusseinAyalew Tefferi
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Paolo BaldoLorenzo Moja
Jun 1, 2010·Expert Opinion on Pharmacotherapy·Jasmine Zain, Owen O'Connor
Jan 13, 2012·Acta Haematologica·Jung Ha KimJin Yong Kim
Aug 29, 2012·Case Reports in Medicine·Yoshiko TakahashiKazuo Chihara
Sep 10, 2014·Medical Oncology·Hany A LabibNeveen G Elantonuy
Jul 25, 2017·Cytopathology : Official Journal of the British Society for Clinical Cytology·S SadafM A Yusuf
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory D LeonardWyndham H Wilson
Feb 20, 2003·Journal of Hematotherapy & Stem Cell Research·Mirna SucićAna Stavljenić-Rukavina

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.